33839159

Summary
Title
Discovery of amivantamab (JNJ-61186372), a bispecific antibody targeting EGFR and MET.
Authors
  • Neijssen J
  • Cardoso RMF
  • Chevalier KM
  • Wiegman L
  • Valerius T
  • Anderson GM
  • Moores SL
  • Schuurman J
  • Parren PWHI
  • Strohl WR
  • Chiu ML
Source
J Biol Chem
Publication Date
2021 Jan-Jun
PubMed ID
33839159

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024